Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel assay of cardiac markers (RATPAC) trial

Fitzgerald, P., Goodacre, S., Cross, E. and Dixon, S. and On behalf of the RATPAC research team (2011) Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel assay of cardiac markers (RATPAC) trial. Academic Emergency Medicine, 18 (5). pp. 488-495. ISSN 1069-6563

Full text not available from this repository

Publisher's URL: http://dx.doi.org/10.1111/j.1553-2712.2011.01068.x


Item Type:Article
Uncontrolled Keywords:cost-effectiveness, point-of-care biomarker assessment, suspected myocardial infarction, randomized assessment, treatment, panel assay, cardiac markers, RATPAC
ID Code:15281
Deposited By: Professor J. Benger
Deposited On:14 Jul 2011 11:33
Last Modified:12 Aug 2013 08:06

Request a change to this item

Copyright 2013 © UWE better together